Pricing Log in Create free account

GENPREX (GNPX) vs Iterum Therapeutics PLC (ITRMF)

GENPREX and Iterum Therapeutics PLC are both Biotechnology companies. GENPREX is the larger, with a market value of $1.9M against $1.6M — 1.2× the size. Iterum Therapeutics PLC has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. GENPREX has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 13 metrics below, GENPREX leads on 8 and Iterum Therapeutics PLC on 5.

Valuation

Metric GNPX ITRMF Biotechnology median
P/E 0.03 n/m 8.50
P/S n/m n/m 9.71
P/B 0.07 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.89 n/m 0.64
EV/Sales n/m 24.37 9.21
Earnings yield 3,170.61% 0.00% (33.15%)
Free cash flow yield (1,481.72%) 0.00% (25.50%)

Profitability

Metric GNPX ITRMF Biotechnology median
Gross margin 0.00% (81.85%) 65.16%
Operating margin 0.00% (2,243.48%) 0.00%
Net margin 0.00% (2,930.54%) 0.00%
Free cash flow margin 0.00% (2,122.61%) 0.00%
Return on equity (203.86%) 285.48% (56.36%)
Return on assets (157.40%) (111.35%) (48.04%)
Return on invested capital 0.00% (455.51%) 0.00%

Growth

Metric GNPX ITRMF Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 93.48% 57.43% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNPX ITRMF Biotechnology median
Debt to equity 0.00 (2.87) 0.00
Current ratio 6.76 2.13 4.72
Net debt to EBITDA 0.50 0.24 0.96

Dividend

Metric GNPX ITRMF Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNPX ITRMF Biotechnology median
Market cap 1.88m 1.59m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack